Posted On: 10/31/2014 7:23:40 PM
Post# of 30067
Amarantus is like watching Cirque Du Soleil. There are so many things going on all at once, it's hard to take it all in. Lympro, Eltoprazine, MANF, Phenoguard, etc.
People react to one performer while losing sight of the entire performance. This is why a "spin-on" is desirable to unlock the true value of the assets. What is each asset truly worth today, tomorrow, next year? The current price doesn't even recognize Lympro let alone the rest, but that will change shortly.
If you go back and read the quarterly update transcript from the Nov. 18, 2013 call, it's interesting so see what the thoughts, plans, hopes were back then and what Amarantus has been able to accomplish in just a year.
BTW - Oct. 28th marked their 1st year anniversary at Janssen Labs. I remember a year ago when moving there was a big deal and still is.
People react to one performer while losing sight of the entire performance. This is why a "spin-on" is desirable to unlock the true value of the assets. What is each asset truly worth today, tomorrow, next year? The current price doesn't even recognize Lympro let alone the rest, but that will change shortly.
If you go back and read the quarterly update transcript from the Nov. 18, 2013 call, it's interesting so see what the thoughts, plans, hopes were back then and what Amarantus has been able to accomplish in just a year.
BTW - Oct. 28th marked their 1st year anniversary at Janssen Labs. I remember a year ago when moving there was a big deal and still is.
(0)
(0)
